Atomoxetine for Treating ADHD in Children
Author Information
Author(s): Christopher J. Kratochvil, Denái R. Milton, Brigette S. Vaughan, Laurence L. Greenhill
Primary Institution: University of Nebraska Medical Center
Hypothesis
Does atomoxetine differ in efficacy and tolerability between younger (6-7 years) and older (8-12 years) children with ADHD?
Conclusion
Atomoxetine is effective and generally well-tolerated for treating ADHD in both younger and older children.
Supporting Evidence
- Atomoxetine significantly reduced ADHD symptoms in both age groups compared to placebo.
- Younger children experienced more severe ADHD symptoms at baseline than older children.
- The treatment was well tolerated, with few discontinuations due to adverse events.
Takeaway
Atomoxetine helps kids with ADHD feel better, and it works well for both younger and older kids.
Methodology
Meta-analysis of six randomized, double-blind, placebo-controlled trials.
Potential Biases
Potential for publication bias due to the nature of included studies.
Limitations
Short treatment duration and variations in study design may limit the findings.
Participant Demographics
1,140 subjects aged 6-12 years; 74% male, 71% Caucasian.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website